| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0008500 | Exon-Exon | chr16:68160351-68215433 | chr16:68126448-68181530 | 56 nt | 0.4821 |
| hsa_NFATC3_0008600 | Exon-Exon | chr16:68160351-68217269 | chr16:68126448-68183366 | 687 nt | 0.4221 |
| hsa_NFATC3_0008700 | Intron-Exon-Intron | chr16:68168122-68208417 | chr16:68134219-68174514 | 314 nt | 0.4013 |
| hsa_NFATC3_0008800 | Intron-Exon-Intron | chr16:68172414-68208417 | chr16:68138511-68174514 | 250 nt | 0.2960 |
| hsa_NFATC3_0008900 | Intron-Exon-Intron | chr16:68172414-68217269 | chr16:68138511-68183366 | 127 nt | 0.4331 |
| hsa_chr16_0275700 | Intergenic-Intergenic | chr16:68173982-68176583 | chr16:68140079-68142680 | 2602 nt | 0.3870 |
| hsa_NFATC3_0009000 | Intron-Intron | chr16:68177663-68178655 | chr16:68143760-68144752 | 993 nt | 0.3666 |
| hsa_NFATC3_0009100 | Intron-Intron | chr16:68178433-68178838 | chr16:68144530-68144935 | 406 nt | 0.5000 |
| hsa_NFATC3_0009200 | Intron-Intron | chr16:68179593-68179875 | chr16:68145690-68145972 | 283 nt | 0.3675 |
| hsa_NFATC3_0009300 | Intron-Intron | chr16:68179606-68179860 | chr16:68145703-68145957 | 255 nt | 0.3490 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].